ARQT FY 2021 Earnings — Arcutis Biotherapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ARQTArcutis Biotherapeutics, Inc.

$3B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$763,000

Operating Income

-$207M

Net Income

-$206M

EPS (Diluted)

$-4.17

Cash Flow

Operating Cash Flow

-$175M

Free Cash Flow

-$176M

Stock-Based Comp.

$24M

Balance Sheet

Total Assets

$408M

Total Liabilities

$110M

Stockholders' Equity

$298M

Cash & Equivalents

$98M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$763,000	-$455,000	-67.7%
Operating Income	-$207M	-$137M	-51.1%
Net Income	-$206M	-$136M	-52.1%